Skip to main content
Journal cover image

Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial

Publication ,  Conference
Strickler, JH; Zemla, T; Ou, F-S; Cercek, A; Wu, C; Sanchez, FA; Hubbard, J; Jaszewski, B; Bandel, L; Schweitzer, B; Niedzwiecki, D; Kemeny, N ...
Published in: ANNALS OF ONCOLOGY
October 1, 2019

Duke Scholars

Published In

ANNALS OF ONCOLOGY

EISSN

1569-8041

ISSN

0923-7534

Publication Date

October 1, 2019

Volume

30

Location

Barcelona, SPAIN

Publisher

OXFORD UNIV PRESS

Conference Name

44th Congress of the European-Society-for-Medical-Oncology (ESMO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Strickler, J. H., Zemla, T., Ou, F.-S., Cercek, A., Wu, C., Sanchez, F. A., … Bekaii-Saab, T. (2019). Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial. In ANNALS OF ONCOLOGY (Vol. 30). Barcelona, SPAIN: OXFORD UNIV PRESS.
Strickler, J. H., T. Zemla, F. -. S. Ou, A. Cercek, C. Wu, F. A. Sanchez, J. Hubbard, et al. “Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial.” In ANNALS OF ONCOLOGY, Vol. 30. OXFORD UNIV PRESS, 2019.
Strickler JH, Zemla T, Ou F-S, Cercek A, Wu C, Sanchez FA, et al. Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2019.
Strickler JH, Zemla T, Ou F-S, Cercek A, Wu C, Sanchez FA, Hubbard J, Jaszewski B, Bandel L, Schweitzer B, Niedzwiecki D, Kemeny N, Boland PM, Ng K, Bekaii-Saab T. Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2019.
Journal cover image

Published In

ANNALS OF ONCOLOGY

EISSN

1569-8041

ISSN

0923-7534

Publication Date

October 1, 2019

Volume

30

Location

Barcelona, SPAIN

Publisher

OXFORD UNIV PRESS

Conference Name

44th Congress of the European-Society-for-Medical-Oncology (ESMO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis